Background: Dystonia constitutes a heterogeneous group of movement abnormalities, characterized by sustained or intermittent muscle contractions causing
Introduction
Dystonia is the third most prevalent movement disorder and afflicts about 250,000 people in the United States. 1 It comprises a highly heterogeneous group of movement abnormalities, characterized by sustained or intermittent muscle contractions causing abnormal, repetitive movements and postures, or both. 2 Symptoms can develop in children or adults. They can affect a single body part, multiple segments or be generalized. This phenotypical heterogeneity may or may not reflect diverse etiology. Indeed, well-defined monogenic hereditary dystonias have variable age of onset, affected body parts, and rate of progression. 3 A new categorization of dystonia distinguishes those with only dystonia as isolated dystonia. This review focuses primarily on those with isolated dystonia that is either caused by a known genetic mutation or is idiopathic (formerly called primary dystonias). 2 Poor understanding of underlying pathophysiology, inadequate animal models and absence of biomarkers have limited
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The Center for Digital Research and Scholarship Columbia University Libraries/Information Services development of adequate therapeutics for isolated idiopathic or genetic dystonias. Historically dystonia has been considered a basal ganglia disorder, with numerous lines of evidence suggesting involvement of the dopaminergic system. However, dysfunction of other brain regions and circuits has become increasingly evident. Focal dystonias have been associated with impaired inhibition in the somatosensory cortex and abnormal sensorimotor processing beyond those parts of the brain that represent the symptomatic body part. [4] [5] [6] [7] [8] Structural and functional imaging studies show dysfunction of the cerebellum or defects in its connections in isolated idiopathic dystonias. 9-15 Indeed, most researchers agree that dystonia is associated with physiologic abnormalities at multiple levels involving cortico-ponto-cerebello-thalamo-cortical and cortico-basal ganglia-thalamo-cortical pathways. [16] [17] [18] Nevertheless, emerging evidence indicates TOR1A, GNAL and ANO3 mutations produce functional changes that converge to affect striatal signal transduction pathways. [19] [20] [21] Such findings underscore possible commonalities across at least some of these heterogeneous conditions. Neuroimaging offers a non-invasive method to examine structural and functional changes in humans. Initially, molecular imaging studies of dopaminergic pathways relied on 6-fluorodopa ([ Major advances in molecular imaging, with development of more specific radioligands along with sophisticated analysis methods, permit greater in-depth study of dopaminergic pathways. Similarly, positron emission tomography (PET) and functional magnetic resonance imaging (fMRI)-based blood oxygen leveldependent (BOLD) measures have been used to investigate task-related activation of dopaminergic pathways. Resting state fMRI (rs-fMRI) and diffusion tensor imaging (DTI) studies assess functional and structural connectivity of cortico-basal ganglia-thalamo-cortical circuits. Stronger magnets (3 T and higher) and more advanced data analyses have strengthened these studies. Admittedly, each of these methods provides only a limited indirect view of dopaminergic pathways. In this review, we critically evaluate recent neuroimaging studies that shed light on the involvement of dopaminergic pathways by investigating dopamine receptors, endogenous dopamine release, morphology of striatum and downstream targets, and structural or functional connectivity in corticobasal ganglia-thalamo-cortical and related cerebellar circuits.
Methods
A PubMed search in August 2014 with keyword combinations dystonia, PET, dopamine; dystonia MRI, dopamine; and dystonia, SPECT, dopamine yielded 141, eight, and 58 entries, respectively. We considered only studies pertaining to the dopaminergic system or relevant pathways in idiopathic or hereditary dystonias.
Dopaminergic pathways
A model of basal ganglia circuitry includes cortical-striato-pallidothalamic-cortical loops with primary input into striatum (putamen and caudate) from cortical glutamatergic, thalamostriatal glutamatergic, and nigral dopaminergic projections. [22] [23] [24] Two major pathways lead from the striatum to the main output nucleus in the basal ganglia internal segment of the pallidum (GPi) and substantia nigra pars reticulate (SNpr): 1) the direct pathway via inhibitory GABAergic fibers, and 2) the indirect pathway, including inhibitory GABAergic neurons to GPe (external segment of GP), inhibitory neurons projecting from GPe to subthalamic nucleus (STN), and excitatory glutamatergic neurons projecting from STN to GPi/SNr. GPi/SNr send inhibitory GABAergic neurons to the ventral anterior thalamus that project via excitatory neurons to cortical areas, including the premotor and motor regions. Multiple studies suggest that the direct pathway selects the desired movement (facilitation), while the indirect pathway suppresses unwanted surrounding movement (inhibition).
25
Dystonia could represent a defect in surround inhibition (abnormal function of the indirect pathway) perhaps coupled with excessive facilitation of the intended movement (overactivation of the direct pathway).
26
Dopaminergic nigrostriatal input regulates the activity in direct and indirect pathways. Indeed, the nigrostriatal dopaminergic fibers terminate on the shafts of the dendritic spines of the medium spiny neurons (MSNs) 27 Nigrostriatal fibers express presynaptic D2R and D3R (autoreceptors) as well, which are inhibitory and their activation reduces the dopamine release at the synaptic cleft between nigrostriatal fibers and medium spiny neurons.
Molecular imaging and dopamine receptors
Many observations suggest that dysfunction of D2-like receptors underlies the pathophysiology of idiopathic and some acquired forms of dystonia. Exposure to drugs that block D2-like receptors can cause acute dystonia.
39-41 Non-human primates treated with intracartoid MPTP
(1-methyl-4-phenyl-1,2 3,6-tetrahydropyridine) develop transient dystonia. 50 Other studies report reduced striatal [
11 C]raclopride uptake, which has a low selectivity for 5-HT(2A) but near equal selectivity for D2R and D3R
48,51 and can be displaced by endogenous dopamine. 52 Such displacement can confound interpretation of reduced raclopride uptake, which can indicate either reduced D2-like binding sites or increased competition with elevated striatal dopamine. However, subsequent studies with the highly selective D2R radioligand N-methylbenperidol (NMB) did not identify reduced striatal uptake in isolated idiopathic hand or cranial dystonia. Since NMB is 200-fold more selective for D2R than D3R and is not displaced by endogenous dopamine, these findings suggest that previously reported reduced striatal D2-like binding may reflect a reduction in striatal D3R rather than a change in D2R.
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D3R could play a role in pathophysiology of dystonia through presynaptic autoregulatory receptor sites, a regulatory effect on dopamine transporter, or interaction with D1-like receptors. [54] [55] [56] Proof of this hypothesis requires PET studies with D3R-selective radioligands. Such radioligands have been developed and successfully used in non-human primate studies 51 but no studies in humans have yet been reported. Alternatively, if changes in endogenous dopamine affect dopamineselective radioligands, an alteration of striatal dopamine concentration could explain apparent differences in striatal radioligand uptake. Reports of post-mortem striatal dopamine levels reveal contradictory results.
57, 58 Voxel-wise analysis of task-induced striatal dopamine release revealed decreased [ 11 C]raclopride displacement with a motor task involving the affected body part in patients with laryngeal dystonia compared with healthy controls. In contrast, a motor task of an uninvolved body part elicited an increased striatal [ 11 C]raclopride displacement in the same patients compared with healthy controls. 59 These findings suggest altered striatal dopamine release compared with healthy controls. An analogous study in patients with writer's cramp (another isolated idiopathic dystonia) yielded similar findings, confirming common dopaminergic pathway changes across these two focal isolated idiopathic dystonia subtypes. 59 66 This finding was consistent with a SPECT study revealing normal ( 99m )Tc-TRODAT-1 uptake as a measure of DAT in DRD.
67
Other dystonia types in particular isolated idiopathic focal dystonias have not been examined with these ligands. 77 demonstrated hypermetabolism in the basal ganglia, thalamus, premotor-motor cortex, and cerebellum in the isolated idiopathic cervical dystonia compared with healthy controls. However, an FDG study of a group including generalized dystonia, hemidystonia, and focal dystonias revealed decreased activity in striatum and globus pallidus. 78 Inclusion of hemidystonia, which is commonly an acquired dystonia, clearly confounds interpretation of these findings. Eidelberg and colleagues [79] [80] [81] [82] have applied a principal components analysis method to identify changes in spatial covariance patterns in FDG uptake to define metabolic networks associated with dystonia, and identified increased contributions from posterior putamen, globus pallidus, cerebellum, and SMA (supplemental motor area) in patients with blepharospasm and in DYT1 and DYT6 carriers, regardless of the presence of clinical manifestation. A direct comparison of regional glucose metabolism revealed genotype-related metabolic changes including hypermetabolism in the putamen, anterior cingulate, and cerebellum of DYT1 carriers, and hypometabolism in the putamen and temporal cortex of DYT6 carriers.
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Remarkably, the phenotype-related activity pattern in the same study did not include dopaminergic pathways. rs-fMRI correlations are based on intrinsic fluctuations in the BOLD signal that reflects slow variations in neuronal activity propagating through connected networks. Changes in these fluctuations indicate network dysfunction. 84 Most rs-fMRI studies in isolated idiopathic focal dystonias indicate reduced connectivity in putamen and sensorimotor network regardless of the affected body part (Table 1) . [85] [86] [87] [88] [89] However, a recent study in focal hand dystonia with extensive cortical, subcortical, and cerebellar seeds did not show any difference in putamenal functional connectivity but instead found changes in functional connectivity of the globus pallidus and cerebellum. 90 While most research has focused on investigating the correlations between low-frequency fluctuations, Zhou et al. 91 analyzed the amplitude of these fluctuations, which revealed increased amplitude in the putamen and globus pallidus and decreased amplitude in the somatosensory region, thalamus, and cerebellum. Overall, these rs-fMRI studies were conducted following various protocols with different levels of quality assurance. Multiple comparison and head motion correction are two major concerns in rs-fMRI analyses. Most studies apply a family-wise error rate to correct for multiple comparisons at the subject level, but only a few perform a Bonferroni correction, which is a far more stringent correction at the group level analysis. Some studies do not apply any correction, or apply only small-volume correction for a priori regions (Table 1) . It is not surprising that such a heterogeneous level of control over false discovery can contribute to variable and difficult to reproduce data. Motion-induced signal change is another major challenge in analyzing rs-fMRI data, as it causes spurious misleading correlations. 92 Most recent studies try to address this issue by censoring frames with excessive movement and regressing various parameters such as the global signal, or cerebrospinal fluid and white matter signal, in addition to motion parameters. Indeed in many cases excessive frame censoring could lead to exclusion of the subject from data analysis. 93 However, many dystonia studies do not comment on motion correction measures. Interestingly, no study mentions exclusion of subjects due to excessive frame-to-frame movement. [84] [85] [86] [87] [88] [89] [90] 94 Application of improved analysis and motion correction methods may enhance the quality and reproducibility of findings and reveal new insights into functional consequences of altered dopaminergic pathways as shown in idiopathic Parkinson disease. 93 
Structural imaging and dopamine pathways
Numerous earlier reports showed striatal abnormalities in CT scans of idiopathic or secondary dystonias. [95] [96] [97] [98] With advances in MRI, many studies have measured the gray matter volume of relevant structures such as the caudate and putamen, thalamus and sensorimotor cortex in different dystonia subtypes. Nonetheless, the patient population, number of participants, strength of the magnetic field, data acquisition and the processing method have been highly variable among these The Center for Digital Research and Scholarship Columbia University Libraries/Information Services studies, which could explain the inconsistent findings. In fact, some showed increased, decreased, or no change in putamenal volume. 60, 99, 100 Improved magnetization-prepared rapid gradient-echo (MPRAGE) contrast and stronger magnetic fields may improve the reliability of volumetric measurements in future studies.
Diffusion tensor imaging
Another commonly used structural neuroimaging modality is DTI. It is based on diffusion of water molecules in the tissue and provides information about cellularity and integrity of aligned axons. Fractional anisotropy describes the degree of restriction in water molecule diffusion, 101 such that a higher value is associated with aligned axons.
Mean diffusivity corresponds to diffusion of water molecules and has higher values as the cellularity of the tissue declines. 102 In particular, diffusion tensor tractography permits in vivo mapping of structural connectivity, where white matter fiber trajectories are reconstructed by tracking the direction of fastest diffusion between two targets. Similar to rs-fMRI, early DTI studies in dystonia show highly inconsistent findings, usually including some elements of the basal ganglia, cerebellum, and sensorimotor cortex. 103 DTI findings depend upon the investigated brain regions of interest (ROI). Many early DTI studies did not include measures of basal ganglia connections. Furthermore, most of these early DTI studies employed magnetic resonance scanners with relatively low field strength of 1.5 T.
Fractional anisotropy and mean diffusivity measures vary significantly between 3 T and 1.5 T magnets. 104, 105 A stronger magnetic field presumably improves the signal-to-noise ratio at the cost of greater distortion, which must be addressed. Field map corrections attempt to compensate for low distortions, but such corrections have not yet been applied to most studies. 106 In addition, only a few studies have implemented diffusion tensor tractography to determine structural connectivity. Recent DTI studies have defined microstructural changes such as subgyral white matter abnormalities of the sensorimotor cortex and cerebello-thalamic tracts associated with genotype in both manifesting and non-manifesting DYT1 and DYT6 carriers.
107,108
They have further identified somatotopic white matter changes 109 and thalamocortical tract abnormalities 110 related to clinical phenotype.
However, none of these studies included basal ganglia as ROI for the tractography analysis, hence diffusion tensor tractography measures of dopaminergic pathways remain to be determined in future studies.
Conclusion
Although specific genetic defects may cause some forms of dystonia, in most cases its etiology remains unknown and treatment options unsatisfactory. Neuroimaging can provide a valuable tool to investigate the pathophysiology of dystonias. Overwhelming functional and structural data suggest the involvement of basal ganglia and related networks in various dystonia types. Increasing evidence also suggests dysfunction of cerebellar pathways as a likely cause of dystonia. In fact, a variety of anatomical and functional studies now suggest that cerebellar and basal ganglia pathways are tightly interrelated. 111 Thus, dysfunction of dopaminergic pathways in basal ganglia could alter cerebellar circuits and vice versa. 93 Molecular imaging remains an effective neuroimaging modality to investigate dopaminergic pathway involvement. PET imaging offers strong evidence for altered D2/D3 receptor binding yet may miss factors affecting dopamine homeostasis and the dopamine-related subcellular signaling cascade, which also could alter function of these pathways. The effect of dopamine is largely mediated through the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) signaling cascade and therefore controlled by phosphodiesterases (PDEs). Different PDE isoforms are expressed in striatal dopaminergic terminals, and the medium spiny neurons of direct and indirect pathways. Indeed animal data suggest that PDE10 inhibitors activate an indirect pathway. 112 Novel PET radioligands are available for in vivo human PET studies of PDE10A and should be employed in dystonia research. 113 Further, striatal specific protein Rhes can activate striatal mTOR signaling, which is downstream of the GNAL dystonia gene. Rhes and mTOR are modulated by dopaminergic pathways and mediate striatal plasticity and could play a role in dystonia. 20 Currently no PET ligands are available for in vivo evaluation of these targets. Functional or structural imaging in isolation cannot discern whether altered basal ganglia network connections are causative, epiphenomenon, or compensatory. However, such studies could help identify network patterns suggestive of disease susceptibility, independent of disease manifestation, and serve as subclinical markers of gene expression. Alternatively, they can be used for monitoring target engagement for disease-modifying therapies if the network pattern correlates closely with the phenotype. In addition, functional and structural neuroimaging data can guide histopathological studies. Finally, combining structural and functional imaging with PET will potentiate their effectiveness. Any region with abnormal radioligand binding could serve as the ROI for rs-fMRI and diffusion tensor tractography and provide information on downstream effects of the molecular change. 
